Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

sugammadex

- PMLiVE

New Merck Foundation appoints Rasha Kelej

She takes up role as CEO of the pharma firm's newly-established non-profit

- PMLiVE

Merck & Co’s anacetrapib rescued by positive phase III trial

Data suggests drug reduces MACE compared to placebo

- PMLiVE

Merck confirms sale of biosimilar division

German pharma group is in 'advanced discussions' with potential buyers

- PMLiVE

Avelumab costs peg back profit at Merck KGaA

Development of its immuno-oncology product is central to Merck's healthcare plans

Marketing strategy in complex environments

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what...

Blue Latitude Health

Merck licences MS brain training programme

Strikes deal with HAPPYneuron to bolster its MSdialog platform for Rebif

- PMLiVE

Aduro pancreatic cancer vaccine trial disappoints

Immunotherapy combination fails to improve overall survival over existing treatments

- PMLiVE

Merck appoints ex-Pfizer exec as global head of oncology

Maya Martinez-Davis succeeds Andrew Schiermeier in the role

Digital roundup

Genzyme, Merck, the forthcoming EU clinical trials portal and more

- PMLiVE

Merck appoints new North America and China biopharma leaders

Gary Zieziula and Marc Horn take on new roles

- PMLiVE

Dr Jessie English joins Merck

She will take up the role of vice president of its discovery team

- PMLiVE

Merck finally bags FDA approval for Bridion

Follows three unsuccessful attempts to gain a US licence for the drug

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links